RxDoctor Payments Data

Gayle Spelman

Physician Assistant · Lincoln, NHNPI 1033316658

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AstraZeneca at 39.8% of the total. Reporting peaked in 2024 at $1,237 and has fallen 89.2% since, to $134 in 2025. Among physician assistant clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,132in general payments, 2019–2025

Across 167 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$571
  • AbbVie$535
  • GSK$402
  • Pfizer$180
  • Merck$117
  • plus $683 from 18 others

What the payments were for

  • Food & beverage$4,03298%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,132 in reported general payments places this provider in the 95th percentile of 782 physician assistant providers in New Hampshire.

See all physician assistant providers in New Hampshire

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl15$23,902
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$23,228
FarxigaDapagliflozin Propanediol20$15,668
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,091
OzempicSemaglutide13$12,385
EliquisApixaban13$11,531
XareltoRivaroxaban13$6,995
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$2,432
Bupropion XlBupropion Hcl12$2,204
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine47$1,520
Gabapentin66$1,027
Albuterol Sulfate HfaAlbuterol Sulfate40$937
Omeprazole47$902
Oxycodone Hcl52$605
Trazodone Hcl56$585

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,644$29,76043 claims
AbbVieVraylar$535$23,90215 claims
GSKTrelegy Ellipta$402$23,22829 claims
Novo NordiskOzempic$571$12,38513 claims
PfizerEliquis$180$11,53113 claims
Johnson & JohnsonXarelto$58$6,99513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 782 physician assistant providers in New Hampshire.

Other physician assistant in Lincoln

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →